In biotech, the biggest delays and costs don’t come from science but from communication breakdowns between technical and ...
Explore the revolutionary potential of biotechnology and gene editing, alongside crucial ethical considerations and ...
Australian pharmaceutical and biotechnology start-ups are already looking to take their investments to jurisdictions ...
Analysis of over 5,000 hours of clinical wear data validates Trinity Biotech’s CGM+ 's purpose-built capability to distinguish nocturnal compression-related false lows from true blood glucose lows - ...
By Deena Beasley June 30 (Reuters) - The chair of the U.S. House Select Committee on China opened national security ...
The FDA dealt Lantheus’ bid to garner approval of its radiodiopharmaceutical diagnostic kit a setback due to manufacturing issues at a third-party facility. (Stock Photo ) The FDA dealt Lantheus’ bid ...
What do Botox, rat poison, weight-loss drugs and a fictional murder investigation have in common? At the University of Nevada ...
Highlights Significant Clinical, Regulatory, and Strategic Progress, Supported by a Disciplined Capital Allocation Strategy ...
Abivax stock rebounds as new trial data eases safety concerns over ulcerative colitis drug ...
A medicinal chemist at a biotech company decided to take matters into his own hands after a coworker escalated a simple labeling mistake to management. What could have been a minor error turned into a ...
Healthcare Opportunities Fund tops healthcare CEFs for 2026, with an 11.53% yield and a -5.97% NAV discount. Click here to read more about THQ.
A handful of start-up firms are testing therapies that target specific epigenetic markers to treat everything from high ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results